A study of the treatment of hallucinations and sleep disturbances in Parkinson's disease

This is a single-center study of the treatment of hallucinations and sleep disturbances in Parkinson disease patients. Rush University Medical Center plans to study 30 subjects who will be assigned by chance to one of two study groups (15 per study treatment group). Subjects will be assigned to either a study drug or to placebo (inactive/sugar pill). 

You may be eligible to participate in this study if you:

• Are a male or female between the ages of 40 and 85 years of age
• Are a patient with idiopathic Parkinson disease who have troublesome sleep disturbances and chronic hallucinations as determined by the movement disorders physician at the time of the office visit
• Are a patients with chronic hallucinations (visual, auditory, tactile, or olfactory), two or more times/week for at least two months that are bothersome to patient and caregiver
• Are a patients with troublesome nocturnal sleep disturbances

You will be excluded from this study if you:

• Are a patients with atypical or secondary parkinsonism
• Are a patients currently treated with antipsychotic medication

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.